Marissa King
Marissa King
Professor of Organizational Behavior
Verified email at yale.edu
Title
Cited by
Cited by
Year
Diagnostic change and the increased prevalence of autism
M King, P Bearman
International journal of epidemiology 38 (5), 1224-1234, 2009
5732009
Benzodiazepine use in the United States
M Olfson, M King, M Schoenbaum
JAMA psychiatry 72 (2), 136-142, 2015
5282015
Social influence and the autism epidemic
KY Liu, M King, PS Bearman
American journal of sociology 115 (5), 1387-1434, 2010
3132010
Age of diagnosis for autism: individual and community factors across 10 birth cohorts
C Fountain, MD King, PS Bearman
Journal of Epidemiology & Community Health 65 (6), 503-510, 2011
3082011
Social movements and organizational form: Cooperative alternatives to corporations in the American insurance, dairy, and grain industries
M Schneiberg, M King, T Smith
American Sociological Review 73 (4), 635-667, 2008
3052008
Socioeconomic status and the increased prevalence of autism in California
MD King, PS Bearman
American sociological review 76 (2), 320-346, 2011
1982011
Treatment of young people with antipsychotic medications in the United States
M Olfson, M King, M Schoenbaum
JAMA psychiatry 72 (9), 867-874, 2015
1672015
Estimated autism risk and older reproductive age
MD King, C Fountain, D Dakhlallah, PS Bearman
American Journal of Public Health 99 (9), 2009
1282009
Association between payments from manufacturers of pharmaceuticals to physicians and regional prescribing: cross sectional ecological study
W Fleischman, S Agrawal, M King, AK Venkatesh, HM Krumholz, ...
bmj 354, 2016
1162016
Medical school gift restriction policies and physician prescribing of newly marketed psychotropic medications: difference-in-differences analysis
M King, C Essick, P Bearman, JS Ross
Bmj 346, 2013
992013
Antislavery in America: The press, the pulpit, and the rise of antislavery societies
MD King, HA Haveman
Administrative Science Quarterly 53 (3), 492-528, 2008
742008
The spatial structure of autism in California, 1993–2001
S Mazumdar, M King, KY Liu, N Zerubavel, P Bearman
Health & place 16 (3), 539-546, 2010
542010
Gifts and influence: Conflict of interest policies and prescribing of psychotropic medications in the United States
M King, PS Bearman
Social Science & Medicine 172, 153-162, 2017
45*2017
Medical adaptation to academic pressure: schooling, stimulant use, and socioeconomic status
MD King, J Jennings, JM Fletcher
American Sociological Review 79 (6), 1039-1066, 2014
382014
The geography of antidepressant, antipsychotic, and stimulant utilization in the United States
M King, C Essick
Health & place 20, 32-38, 2013
352013
National patterns of commonly prescribed psychotropic medications to young people
RS Sultan, CU Correll, M Schoenbaum, M King, JT Walkup, M Olfson
Journal of child and adolescent psychopharmacology 28 (3), 158-165, 2018
332018
Burnout at work isn’t just about exhaustion. It’s also about loneliness
E Seppala, M King
Harvard Business Review 29, 2-4, 2017
272017
Trends in buprenorphine treatment in the United States, 2009-2018
M Olfson, VS Zhang, M Schoenbaum, M King
Jama 323 (3), 276-277, 2020
212020
Working to address the loneliness epidemic: Perspective-taking, presence, and self-disclosure
M King
American Journal of Health Promotion 32 (5), 1315-1317, 2018
132018
Stimulant treatment of young people in the United States
M Olfson, M King, M Schoenbaum
Journal of child and adolescent psychopharmacology 26 (6), 520-526, 2016
102016
The system can't perform the operation now. Try again later.
Articles 1–20